Atrium Therapeutics, Inc. - RNA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Chief Scientific Officer | F | D | 11,216.0 | 8.95 | 100,383.2 | 41,441.0 | View | |
| Sep 22, 2026 | Chief Medical Officer | F | D | 21,459.0 | 8.95 | 192,058.05 | 51,638.0 | View | |
| Sep 22, 2026 | — | F | D | 22,812.0 | 8.95 | 204,167.4 | 31,974.0 | View | |
| Sep 22, 2026 | — | F | D | 126,418.0 | 8.95 | 1,131,441.1 | 138,668.0 | View | |
| Sep 22, 2026 | See Remarks | F | D | 2,375.0 | 8.95 | 21,256.25 | 33,085.0 | View | |
| Sep 22, 2026 | See Remarks | F | D | 11,632.0 | 8.95 | 104,106.4 | 119,729.0 | View | |
| Sep 22, 2026 | Chief Financial Officer | F | D | 6,742.0 | 8.95 | 60,340.9 | 36,859.0 | View | |
| Sep 22, 2026 | Chief Strategy Officer | F | D | 8,320.0 | 8.95 | 74,464.0 | 38,340.0 | View | |
| Apr 22, 2026 | See Remarks | A | A | 60,000.0 | 0.0 | 0.0 | 60,000.0 | View | |
| Apr 22, 2026 | See Remarks | A | A | 30,000.0 | 0.0 | 0.0 | 35,460.0 | View | |
| Apr 22, 2026 | Chief Medical Officer | A | A | 60,000.0 | 0.0 | 0.0 | 60,000.0 | View | |
| Apr 22, 2026 | Chief Medical Officer | A | A | 30,000.0 | 0.0 | 0.0 | 73,097.0 | View | |
| Apr 22, 2026 | Chief Financial Officer | A | A | 60,000.0 | 0.0 | 0.0 | 60,000.0 | View | |
| Apr 22, 2026 | Chief Financial Officer | A | A | 30,000.0 | 0.0 | 0.0 | 43,601.0 | View | |
| Apr 22, 2026 | See Remarks | A | A | 205,000.0 | 0.0 | 0.0 | 205,000.0 | View | |
| Apr 22, 2026 | See Remarks | A | A | 102,500.0 | 0.0 | 0.0 | 131,361.0 | View | |
| Apr 22, 2026 | Chief Strategy Officer | A | A | 60,000.0 | 0.0 | 0.0 | 60,000.0 | View | |
| Apr 22, 2026 | Chief Strategy Officer | A | A | 30,000.0 | 0.0 | 0.0 | 46,660.0 | View | |
| Apr 22, 2026 | Chief Scientific Officer | A | A | 60,000.0 | 0.0 | 0.0 | 60,000.0 | View | |
| Apr 22, 2026 | Chief Scientific Officer | A | A | 30,000.0 | 0.0 | 0.0 | 52,657.0 | View |